Lyme disease has become one of the most
underreported, underrecognized, and difficult
to manage infectious diseases of 21st Century.
Its name originates from the first recognized
case in the small town of Lyme, Conneticut
and the causative factor -a spirochete bacteria
belonging to Borrelia family was discovered
by Dr. Burgdorfer in 1982. The organism
was subsequently named Borrelia burgdorferi.
According to the Center for Disease Control
in Atlanta there are about 200 000 cases
have been reported but it is estimated by
many researchers the actual number of cases
can be as high as ten times more than that.
Borrelia burgdorferi. is very tough
bacteria, resistant to treatments and quite
difficult to detect by routine laboratory
testing . According to many formal and informal
studies this spirochete is present in many
patients suffering from many types of disorders
including Chronic Fatigue Syndrome, Fibromyalgia,
Systemic Lupus, Rheumatoid Arthritis, Scleroderma,
other autoimmune disorders, as well as many
neurological conditions including Multiple
Sclerosis, Bell's Palsy, ALS , Alzheimer's
Disease and more.
Lyme disease is a primarily a tick-borne
disease . Because ticks can carry other
infectious organism along with the Borrelia
burgdorferi, many patients with Lyme's
suffer from infections of Babesia,
Ehrlichia, Chlamydia, Bartonella,
Mycoplasma, as well as viral, fungal
and parasitic organisms.
Presently the only available treatment
in conventional medicine is prolonged antibiotic
therapy which requires a long-term commitment
and life style adjustment. (lost work, severe
complications, etc.) and often yields dissapointing
At Manhattan Advanced Medicine we treat
Lyme disease with very promising results
utilizing the Biological Medicine principles
of individual program treatment which in
most cases require:
1. General detoxification
2. The strengthening of the immune system
3. The elimination of other neurotoxins
4. Nutritional support
The administration of a modified intravenous
antimicrobial treatment protocol originally developed by the Bradford Research Institute.
The final phase of therapy utilizes Intravenous
Lipid Exchange in order to rebuild the cellular
membranes damaged by the infectious organism
and/or its related toxins.
Most of our patients are referred to us from other patients who have had very positive results. Please realize that results are variable and their experience may not be representative of what yours will be. We cannot and do not guarantee any particular outcome from treatment at our center.